clinical trial · NCT05445895
A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
SK Chemicals Co., Ltd.·phase4·completed·n = 483
Ischemic StrokeRenexin CR 200/160mgPlavix 75mg
brief summary
A study to Evaluate the Efficacy and Safety of Renexin CR in patients with Acute Non-cardioembolic Ischemic Stroke
started
Dec 16, 2022
primary completion
Oct 2, 2025
completion
Nov 7, 2025
last updated
Nov 21, 2025
official title
A Prospective, Randomized, Active-controlled, Double-blind, Parallel, Multi-center, Phase IV, Exploratory Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol